Lipfendra (enlicitide) is a new once-daily pill that lowers LDL (“bad”) cholesterol by blocking a liver protein called PCSK9, while statins lower LDL by slowing cholesterol production in the liver itself. The FDA approved Lipfendra as the first oral PCSK9 inhibitor, giving patients pill-based access to a drug class that previously required injections. Here’s the short version:
- Lipfendra cut LDL by 56-59% in clinical trials, on top of existing treatment
- Statins remain the cheaper, longer-tested, first-line option for most people
- Cost is the biggest gap: Lipfendra runs about $315 for a 30-day supply, while generic statins can cost as little as $4-$15 a month
What Is Lipfendra (Enlicitide)?
Lipfendra is the brand name for enlicitide, an oral PCSK9 inhibitor made by Merck. The FDA approved it in July 2026 for adults with high cholesterol (hypercholesterolemia), including an inherited form called heterozygous familial hypercholesterolemia (HeFH).
PCSK9 is a protein that breaks down the liver’s LDL receptors. Lipfendra blocks PCSK9, which lets the liver keep more receptors active and pull more LDL cholesterol out of the bloodstream. Until now, this mechanism was only available through injectable drugs like Repatha and Praluent. Lipfendra is the first version you swallow as a 20 mg tablet.
Key facts about Lipfendra:
- Taken once daily, in the morning, on an empty stomach
- Swallowed whole — never split, crushed, or chewed
- No generic version currently available
- Approved based on two trials totaling 3,207 adults, most of whom were already on statin therapy
- Built on a “macrocyclic peptide” — a ring-shaped molecule engineered to latch onto PCSK9 and block it, which is what lets it work as a pill instead of an injection
Importantly, Lipfendra isn’t positioned as a first-line drug. As one clinical breakdown of the approval explains, doctors typically reserve it for patients whose LDL is still too high despite moderate- or high-intensity statin therapy — not as a starting treatment for someone newly diagnosed with high cholesterol.
High cholesterol is common: roughly 1 in 4 U.S. adults have elevated LDL, according to the American Heart Association, yet CDC estimates suggest only about half of adults who could benefit from cholesterol medication are actually taking one.
What Are Statins?
Statins are the most widely prescribed cholesterol medication in the world. Common examples include atorvastatin (Lipitor), rosuvastatin (Crestor), and simvastatin (Zocor). Rather than removing LDL from the blood directly, statins block an enzyme in the liver that the body needs to manufacture cholesterol in the first place. With less cholesterol being made, the liver pulls more LDL out of circulation to make up the difference.
Statins have been on the market for decades, come in low, moderate, and high-intensity doses, and are backed by some of the largest cardiovascular outcome trials ever conducted.
Lipfendra vs Statins: How They Compare
| Lipfendra (enlicitide) | Statins | |
|---|---|---|
| Drug class | Oral PCSK9 inhibitor | HMG-CoA reductase inhibitor |
| LDL reduction | 56-59% (added to existing treatment) | ~30% (low-intensity) to ~50%+ (high-intensity) |
| Dosing | Once daily, empty stomach, morning | Once daily, any time (often evening) |
| Track record | Approved July 2026 — newest option | Used safely for over 35 years |
| Availability | Brand-name only | Widely available as low-cost generics |
| Typical role | Add-on when statins alone aren’t enough | First-line treatment for most patients |
Side Effects Compared
Common Lipfendra Side Effects
According to WebMD’s drug reference, the most frequently reported side effects of Lipfendra are:
- Diarrhea
- Dizziness
Serious Lipfendra Side Effects
Less common but more serious reactions include:
- Trouble breathing or wheezing
- Swelling of the face, lips, tongue, or throat
- Racing heartbeat
- Hives or skin rash
- Joint pain
Stop taking Lipfendra and get medical help right away if any of these occur.
Common Statin Side Effects
Statins have a long safety record, but side effects can still happen. Per the Mayo Clinic, the most reported issues are:
- Muscle pain, soreness, or weakness
- Digestive problems
- Mental fuzziness
- Rarely, liver enzyme changes
Interestingly, Mayo Clinic notes that the true rate of statin-related muscle pain is about 5% or less compared with a placebo — much lower than many patients expect, a pattern researchers call the “nocebo effect.”
Cost Comparison: Lipfendra vs Statins
Cost is where these two options diverge the most.
| Lipfendra | Generic Statin | |
|---|---|---|
| List price | About $315 for a 30-day supply (~$10.50/day) | As low as $4-$15/month, often less with a coupon |
| Insurance | Brand/specialty tier; prior authorization likely required | Usually a low copay, or $0 on many formularies |
| Best for | Patients who need extra LDL lowering beyond statins | Most people starting cholesterol treatment |
“The PCSK9 inhibitor class has become more cost-effective over time, but these drugs still cost far more per year than generic statins,” notes cardiologist Dr. Steven Nissen, Chief Academic Officer of the Heart, Vascular, and Thoracic Institute at Cleveland Clinic, in a published analysis of PCSK9 pricing.
Insurers typically require documented statin intolerance or an inadequate LDL response on maximum statin therapy before approving a PCSK9 inhibitor like Lipfendra. That means most people will still try statins first.
Who Might Benefit From Each
Statins are usually the right starting point if you:
- Are newly diagnosed with high cholesterol
- Want the lowest-cost, best-studied option
- Haven’t tried cholesterol medication before
Lipfendra may be worth discussing with your doctor if you:
- Are already on the highest statin dose you can tolerate, but your LDL is still too high
- Can’t tolerate statins due to side effects
- Have HeFH and need more aggressive LDL lowering
- Want a pill instead of an injectable PCSK9 inhibitor
FAQ
Can Lipfendra replace my statin?
Not necessarily. Lipfendra’s clinical trials mostly enrolled patients who were already taking a statin, so it’s typically used as an add-on rather than a straight replacement. Your doctor will decide what’s appropriate for your LDL levels and risk factors.
Is Lipfendra covered by insurance?
Coverage varies by plan. Because it’s a new brand-name specialty drug, most insurers will require prior authorization and proof that statins alone weren’t enough.
Which lowers LDL more, Lipfendra or a statin?
In trials, Lipfendra lowered LDL by 56-59% when added to existing treatment. High-intensity statins alone can lower LDL by roughly 50%. The two aren’t a perfect apples-to-apples comparison since Lipfendra was tested as an add-on, not head-to-head against statins alone.
Does Lipfendra prevent heart attacks and strokes?
That hasn’t been established yet. A larger, longer-term cardiovascular outcomes trial is still underway to answer that question.
Statins remain the proven, affordable first choice for most people with high cholesterol. Lipfendra gives doctors and patients a new pill-based option for the specific group whose LDL stays high even on maximum statin therapy — at a meaningfully higher price. Talk to your doctor about where your LDL numbers stand and whether either option fits your treatment plan.
Disclaimer: The information in this article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician before starting, stopping, or switching any cholesterol medication.
